JP2003528810A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003528810A5 JP2003528810A5 JP2001515309A JP2001515309A JP2003528810A5 JP 2003528810 A5 JP2003528810 A5 JP 2003528810A5 JP 2001515309 A JP2001515309 A JP 2001515309A JP 2001515309 A JP2001515309 A JP 2001515309A JP 2003528810 A5 JP2003528810 A5 JP 2003528810A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- tetrahydro
- methoxy
- pyrimidine
- benzylsulfanyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 description 95
- 125000000217 alkyl group Chemical group 0.000 description 59
- 150000001875 compounds Chemical class 0.000 description 52
- 229910052739 hydrogen Inorganic materials 0.000 description 45
- 239000001257 hydrogen Substances 0.000 description 45
- 102100023724 Melanocortin receptor 4 Human genes 0.000 description 37
- 101710085775 Melanocortin receptor 4 Proteins 0.000 description 37
- 150000002431 hydrogen Chemical group 0.000 description 37
- 229910052736 halogen Inorganic materials 0.000 description 27
- 150000002367 halogens Chemical class 0.000 description 27
- -1 benzocarbonyl Chemical group 0.000 description 26
- 125000003342 alkenyl group Chemical group 0.000 description 25
- 125000003118 aryl group Chemical group 0.000 description 24
- 125000002252 acyl group Chemical group 0.000 description 21
- 125000004093 cyano group Chemical group *C#N 0.000 description 20
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 19
- 125000000304 alkynyl group Chemical group 0.000 description 18
- 125000003545 alkoxy group Chemical group 0.000 description 14
- 125000000623 heterocyclic group Chemical group 0.000 description 13
- 241000124008 Mammalia Species 0.000 description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 229910052717 sulfur Inorganic materials 0.000 description 9
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 150000001721 carbon Chemical class 0.000 description 6
- 125000001624 naphthyl group Chemical group 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 5
- 125000003710 aryl alkyl group Chemical group 0.000 description 5
- 125000004104 aryloxy group Chemical group 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- XWJXXXQFFDDHEK-UHFFFAOYSA-N 1-[[2-[(2-methoxynaphthalen-1-yl)methylsulfanyl]phenyl]methyl]pyrrolidin-3-amine Chemical compound COC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1CN1CCC(N)C1 XWJXXXQFFDDHEK-UHFFFAOYSA-N 0.000 description 4
- KWBJMDZAPHKDFB-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]piperidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CCCCC1 KWBJMDZAPHKDFB-UHFFFAOYSA-N 0.000 description 4
- DYASGHCSJCHRAM-UHFFFAOYSA-N 1-[[3-fluoro-2-(2-naphthalen-1-ylethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(F)=CC=CC=1CN1CCNCC1 DYASGHCSJCHRAM-UHFFFAOYSA-N 0.000 description 4
- QRDFGAHATXGIBR-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methoxy]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C([N+]([O-])=O)C=C1COC1=CC=CC=C1C1=NCCCN1 QRDFGAHATXGIBR-UHFFFAOYSA-N 0.000 description 4
- GLGIWLZTKPEBKS-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-6-ethyl-1,4,5,6-tetrahydropyrimidine Chemical compound N1C(CC)CCN=C1C1=CC=CC=C1SCC1=CC(Br)=CC=C1OC GLGIWLZTKPEBKS-UHFFFAOYSA-N 0.000 description 4
- HMGGFEHSQUFZTI-UHFFFAOYSA-N 2-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methoxymethyl]pyrrolidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1COCC1NCCC1 HMGGFEHSQUFZTI-UHFFFAOYSA-N 0.000 description 4
- VBUILYKEAPKRKE-UHFFFAOYSA-N 2-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CC1=NCCCN1 VBUILYKEAPKRKE-UHFFFAOYSA-N 0.000 description 4
- OQQKRORCCALBOF-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)-n-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]propan-1-amine Chemical compound CC1CCCCN1CCCNCC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 OQQKRORCCALBOF-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
- ZCBPTFJSXQSXMK-UHFFFAOYSA-N [1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]piperidin-2-yl]methanol Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1C(CO)CCCC1 ZCBPTFJSXQSXMK-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- XYZDDOTYDXXWPM-UHFFFAOYSA-N n-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]-n-ethylethanamine Chemical compound CCN(CC)CC1=CC=CC=C1SCC1=CC(Br)=CC=C1OC XYZDDOTYDXXWPM-UHFFFAOYSA-N 0.000 description 4
- 229910014033 C-OH Inorganic materials 0.000 description 3
- 229910014570 C—OH Inorganic materials 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 229910052757 nitrogen Chemical group 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- DHMLFLUIIOQLOJ-UHFFFAOYSA-N 1,3-di(piperidin-1-yl)propan-2-yl n-(2-hexoxyphenyl)carbamate Chemical compound CCCCCCOC1=CC=CC=C1NC(=O)OC(CN1CCCCC1)CN1CCCCC1 DHMLFLUIIOQLOJ-UHFFFAOYSA-N 0.000 description 2
- RGFBAGOHQXOXRY-UHFFFAOYSA-N 1,3-di(piperidin-1-yl)propan-2-yl n-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]carbamate Chemical compound C=1C=CC=C(SCC=2C3=CC=CC=C3C=CC=2)C=1NC(=O)OC(CN1CCCCC1)CN1CCCCC1 RGFBAGOHQXOXRY-UHFFFAOYSA-N 0.000 description 2
- GAZFMSFTOKVZQL-UHFFFAOYSA-N 1-(1-ethylpyrrolidin-2-yl)-n-(naphthalen-1-ylmethyl)-n-(naphthalen-2-ylmethyl)methanamine Chemical compound CCN1CCCC1CN(CC=1C2=CC=CC=C2C=CC=1)CC1=CC=C(C=CC=C2)C2=C1 GAZFMSFTOKVZQL-UHFFFAOYSA-N 0.000 description 2
- SHZPSAKOOSXLBB-UHFFFAOYSA-N 1-(naphthalen-1-ylmethyl)-3-(2-phenylethyl)-1-(2-piperidin-1-ylethyl)thiourea Chemical compound C1CCCCN1CCN(CC=1C2=CC=CC=C2C=CC=1)C(=S)NCCC1=CC=CC=C1 SHZPSAKOOSXLBB-UHFFFAOYSA-N 0.000 description 2
- GIHQQJIHBAIGSO-UHFFFAOYSA-N 1-[2-(2-naphthalen-1-ylethyl)phenyl]ethane-1,2-diamine Chemical compound NCC(N)C1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 GIHQQJIHBAIGSO-UHFFFAOYSA-N 0.000 description 2
- ATZDPWOFOKHOFM-UHFFFAOYSA-N 1-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-n,n-dimethylmethanamine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN(C)C ATZDPWOFOKHOFM-UHFFFAOYSA-N 0.000 description 2
- HIZHZFLGIHIACW-UHFFFAOYSA-N 1-[2-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]phenyl]-5,6-dihydro-4h-pyrimidin-1-yl]ethanone Chemical compound CC(=O)N1CCCN=C1C1=CC=CC=C1SCC1=C(F)C=CC=C1Cl HIZHZFLGIHIACW-UHFFFAOYSA-N 0.000 description 2
- OWTGZNSAINYLEJ-UHFFFAOYSA-N 1-[2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5,6-dihydro-4h-pyrimidin-1-yl]-2-phenylethanone Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1C(=O)CC1=CC=CC=C1 OWTGZNSAINYLEJ-UHFFFAOYSA-N 0.000 description 2
- OJJQCZAOHMHZLQ-UHFFFAOYSA-N 1-[2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5,6-dihydro-4h-pyrimidin-1-yl]-3-methylbutan-1-one Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1C(=O)CC(C)C OJJQCZAOHMHZLQ-UHFFFAOYSA-N 0.000 description 2
- QCIYTUBLCHCWKF-UHFFFAOYSA-N 1-[3-[(5-bromo-2-methoxyphenyl)methylsulfanyl]pyrazin-2-yl]pyrrolidin-3-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=NC=CN=C1N1CC(N)CC1 QCIYTUBLCHCWKF-UHFFFAOYSA-N 0.000 description 2
- DWVZXZWVOVLLNB-UHFFFAOYSA-N 1-[3-[(5-bromo-2-methoxyphenyl)methylsulfanyl]quinoxalin-2-yl]pyrrolidin-3-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=NC2=CC=CC=C2N=C1N1CC(N)CC1 DWVZXZWVOVLLNB-UHFFFAOYSA-N 0.000 description 2
- RCAPUOMCNFOSTP-UHFFFAOYSA-N 1-[4-methoxy-3-[[2-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]sulfanylmethyl]phenyl]ethanone Chemical compound COC1=CC=C(C(C)=O)C=C1CSC1=CC=CC=C1C1=NCCCN1 RCAPUOMCNFOSTP-UHFFFAOYSA-N 0.000 description 2
- UPUQOEPOWHSGPH-UHFFFAOYSA-N 1-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC1=CC=CC=C1CN1CCNCC1 UPUQOEPOWHSGPH-UHFFFAOYSA-N 0.000 description 2
- UWBWBCKISPTABJ-UHFFFAOYSA-N 1-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]pyrrolidin-3-amine Chemical compound C1C(N)CCN1CC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 UWBWBCKISPTABJ-UHFFFAOYSA-N 0.000 description 2
- BCQNKADIWADQCL-UHFFFAOYSA-N 1-[[2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1CN1CCNCC1 BCQNKADIWADQCL-UHFFFAOYSA-N 0.000 description 2
- WODPAVGRLDMTGA-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]-2-(methoxymethyl)pyrrolidine Chemical compound COCC1CCCN1CC1=CC=CC(Cl)=C1SCC1=CC(Br)=CC=C1OC WODPAVGRLDMTGA-UHFFFAOYSA-N 0.000 description 2
- JMUUYBCFUZIXOY-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]azetidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CCC1 JMUUYBCFUZIXOY-UHFFFAOYSA-N 0.000 description 2
- NDPLIKQZAAIEAD-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]piperazine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CCNCC1 NDPLIKQZAAIEAD-UHFFFAOYSA-N 0.000 description 2
- AWVJYNDPVRJZQI-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]pyrrolidin-3-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CC(N)CC1 AWVJYNDPVRJZQI-UHFFFAOYSA-N 0.000 description 2
- IFCDMRMMCXRJEV-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]pyrrolidin-3-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1CC(O)CC1 IFCDMRMMCXRJEV-UHFFFAOYSA-N 0.000 description 2
- IILSKIZWMSVWAI-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]piperazine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CCNCC1 IILSKIZWMSVWAI-UHFFFAOYSA-N 0.000 description 2
- IKYPYTQRZDPPLI-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]pyrrolidin-3-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CC(N)CC1 IKYPYTQRZDPPLI-UHFFFAOYSA-N 0.000 description 2
- WOAQXXVCKUXXIM-UHFFFAOYSA-N 1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]pyrrolidin-3-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CC(O)CC1 WOAQXXVCKUXXIM-UHFFFAOYSA-N 0.000 description 2
- JLYBRUBFGATRBM-UHFFFAOYSA-N 1-[[3-chloro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperazine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1C(Cl)=CC=CC=1CN1CCNCC1 JLYBRUBFGATRBM-UHFFFAOYSA-N 0.000 description 2
- HVDWCFNXMDSFSR-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-yl n-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]carbamate Chemical compound C1N(CC2)CCC2C1OC(=O)NC1=CC=CC=C1SCC1=CC=CC2=CC=CC=C12 HVDWCFNXMDSFSR-UHFFFAOYSA-N 0.000 description 2
- WSXOKTKQMKXUKK-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-yl n-[2-[(2-methylnaphthalen-1-yl)methylsulfanyl]phenyl]carbamate Chemical compound C1N(CC2)CCC2C1OC(=O)NC1=CC=CC=C1SCC1=C2C=CC=CC2=CC=C1C WSXOKTKQMKXUKK-UHFFFAOYSA-N 0.000 description 2
- JSSURDODLIXQJB-UHFFFAOYSA-N 1-methyl-2-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]-5,6-dihydro-4h-pyrimidine Chemical compound CN1CCCN=C1C1=CC=CC=C1SCC1=CC=CC2=CC=CC=C12 JSSURDODLIXQJB-UHFFFAOYSA-N 0.000 description 2
- WBODHADKZJNENR-UHFFFAOYSA-N 1-phenyl-3-piperazin-1-yl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile Chemical compound N#CC1=C2CCCCC2=C(C=2C=CC=CC=2)N=C1N1CCNCC1 WBODHADKZJNENR-UHFFFAOYSA-N 0.000 description 2
- LPFIAUCSSYOSJI-UHFFFAOYSA-N 2-(2-benzhydrylsulfanylphenyl)-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCNC(C=2C(=CC=CC=2)SC(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 LPFIAUCSSYOSJI-UHFFFAOYSA-N 0.000 description 2
- SYACJNJDWOFLPR-UHFFFAOYSA-N 2-(2-benzylsulfanylphenyl)-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=CC=1CSC1=CC=CC=C1C1=NCCCN1 SYACJNJDWOFLPR-UHFFFAOYSA-N 0.000 description 2
- VBGDTCBHSKWUHT-UHFFFAOYSA-N 2-(2-benzylsulfanylphenyl)-4,5-dihydro-1h-imidazole Chemical compound C=1C=CC=CC=1CSC1=CC=CC=C1C1=NCCN1 VBGDTCBHSKWUHT-UHFFFAOYSA-N 0.000 description 2
- ORVKGXPJZJAEEK-UHFFFAOYSA-N 2-(3-aminopropylamino)-6-[(5-bromo-2-methoxyphenyl)methylsulfanyl]benzonitrile Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC(NCCCN)=C1C#N ORVKGXPJZJAEEK-UHFFFAOYSA-N 0.000 description 2
- DJWODOBNDWFNTI-UHFFFAOYSA-N 2-(dimethylamino)ethyl n-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]carbamate Chemical compound CN(C)CCOC(=O)NC1=CC=CC=C1SCC1=CC=CC2=CC=CC=C12 DJWODOBNDWFNTI-UHFFFAOYSA-N 0.000 description 2
- BPGGBTUYXDFQIR-UHFFFAOYSA-N 2-(naphthalen-1-ylmethylsulfanyl)-3-(1,4,5,6-tetrahydropyrimidin-2-yl)aniline Chemical compound C=1C=CC2=CC=CC=C2C=1CSC=1C(N)=CC=CC=1C1=NCCCN1 BPGGBTUYXDFQIR-UHFFFAOYSA-N 0.000 description 2
- KGUYGXACOPYBBV-UHFFFAOYSA-N 2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-(1,4,5,6-tetrahydropyrimidin-2-yl)pyrazine Chemical compound COC1=CC=C(Br)C=C1CSC1=NC=CN=C1C1=NCCCN1 KGUYGXACOPYBBV-UHFFFAOYSA-N 0.000 description 2
- SVPBPRSLWASWKI-UHFFFAOYSA-N 2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-piperazin-1-yl-6,7-dihydroquinoxaline Chemical compound COC1=CC=C(Br)C=C1CSC1=NC2=CCCC=C2N=C1N1CCNCC1 SVPBPRSLWASWKI-UHFFFAOYSA-N 0.000 description 2
- SCCAFPIBEOBGTQ-UHFFFAOYSA-N 2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]benzenecarboximidamide Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C(N)=N SCCAFPIBEOBGTQ-UHFFFAOYSA-N 0.000 description 2
- VWLSDJQSNWMCNW-UHFFFAOYSA-N 2-[1-(2-naphthalen-1-ylethyl)pyrrol-2-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCN1C=CC=C1C1=NCCCN1 VWLSDJQSNWMCNW-UHFFFAOYSA-N 0.000 description 2
- XOTXXSNBMHVICF-UHFFFAOYSA-N 2-[2-(1-benzothiophen-3-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1SC2=CC=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 XOTXXSNBMHVICF-UHFFFAOYSA-N 0.000 description 2
- DLZFOGIKAJESJI-UHFFFAOYSA-N 2-[2-(1-naphthalen-1-ylethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1C(C)SC1=CC=CC=C1C1=NCCCN1 DLZFOGIKAJESJI-UHFFFAOYSA-N 0.000 description 2
- FWPVLIBLPJCPKP-UHFFFAOYSA-N 2-[2-(2,3-dihydro-1,4-benzodioxin-5-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=2OCCOC=2C=1CSC1=CC=CC=C1C1=NCCCN1 FWPVLIBLPJCPKP-UHFFFAOYSA-N 0.000 description 2
- ACJPYKJBCKVDIV-UHFFFAOYSA-N 2-[2-(2-naphthalen-1-ylethyl)-3-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(C(F)(F)F)=CC=CC=1C1=NCCCN1 ACJPYKJBCKVDIV-UHFFFAOYSA-N 0.000 description 2
- GPPWPYMVKYICCM-UHFFFAOYSA-N 2-[2-(2-naphthalen-1-ylethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC1=CC=CC=C1C1=NCCCN1 GPPWPYMVKYICCM-UHFFFAOYSA-N 0.000 description 2
- RTLGWGUKVAYFGQ-UHFFFAOYSA-N 2-[2-(2-naphthalen-1-ylethyl)phenyl]ethanamine Chemical compound NCCC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 RTLGWGUKVAYFGQ-UHFFFAOYSA-N 0.000 description 2
- HQKSAFODQJVAMY-UHFFFAOYSA-N 2-[2-(9h-fluoren-9-ylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCNC(C=2C(=CC=CC=2)SC2C3=CC=CC=C3C3=CC=CC=C32)=N1 HQKSAFODQJVAMY-UHFFFAOYSA-N 0.000 description 2
- HLXFXORVYDASPB-UHFFFAOYSA-N 2-[2-(cyclohexylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCCCC1CSC1=CC=CC=C1C1=NCCCN1 HLXFXORVYDASPB-UHFFFAOYSA-N 0.000 description 2
- QDZMJIFWBKCDIU-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylmethoxy)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1COC1=CC=CC=C1C1=NCCCN1 QDZMJIFWBKCDIU-UHFFFAOYSA-N 0.000 description 2
- WUXIBNPXDCPMEH-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 WUXIBNPXDCPMEH-UHFFFAOYSA-N 0.000 description 2
- UWVOBSJHFFRYJU-UHFFFAOYSA-N 2-[2-(naphthalen-1-yloxymethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1OCC1=CC=CC=C1C1=NCCCN1 UWVOBSJHFFRYJU-UHFFFAOYSA-N 0.000 description 2
- FIZAQPWFWADZQW-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylsulfanylmethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1C1=NCCCN1 FIZAQPWFWADZQW-UHFFFAOYSA-N 0.000 description 2
- PTYYJYFKWLYTJJ-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylsulfanylmethyl)phenyl]-4,5-dihydro-1h-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1C1=NCCN1 PTYYJYFKWLYTJJ-UHFFFAOYSA-N 0.000 description 2
- VJKACOCRHHQFEQ-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylsulfanylmethyl)phenyl]piperidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CC=CC=C1C1CCCCN1 VJKACOCRHHQFEQ-UHFFFAOYSA-N 0.000 description 2
- GKFNKZYRWRRHJJ-UHFFFAOYSA-N 2-[2-(naphthalen-1-ylsulfanylmethyl)thiophen-3-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1SC=CC=1C1=NCCCN1 GKFNKZYRWRRHJJ-UHFFFAOYSA-N 0.000 description 2
- ZLJUCWCUFIZEDW-UHFFFAOYSA-N 2-[2-[(2,5-dichlorophenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound ClC1=CC=C(Cl)C(SCC=2C(=CC=CC=2)C=2NCCCN=2)=C1 ZLJUCWCUFIZEDW-UHFFFAOYSA-N 0.000 description 2
- WWNCZFPVXCKTNW-UHFFFAOYSA-N 2-[2-[(2,5-dimethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(OC)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 WWNCZFPVXCKTNW-UHFFFAOYSA-N 0.000 description 2
- SUSFCKRSJXFKFJ-UHFFFAOYSA-N 2-[2-[(2,5-dimethoxyphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(OC)C(SCC=2C(=CC=CC=2)C=2NCCCN=2)=C1 SUSFCKRSJXFKFJ-UHFFFAOYSA-N 0.000 description 2
- USWIGGWFARNAIT-UHFFFAOYSA-N 2-[2-[(2,5-dimethylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=C(C)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 USWIGGWFARNAIT-UHFFFAOYSA-N 0.000 description 2
- IIXSESNTPZDVOB-UHFFFAOYSA-N 2-[2-[(2,6-difluorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC1=CC=CC(F)=C1CSC1=CC=CC=C1C1=NCCCN1 IIXSESNTPZDVOB-UHFFFAOYSA-N 0.000 description 2
- KEFSOJHGKGLWGI-UHFFFAOYSA-N 2-[2-[(2,6-dimethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC(OC)=C1CSC1=CC=CC=C1C1=NCCCN1 KEFSOJHGKGLWGI-UHFFFAOYSA-N 0.000 description 2
- FGRRSCLWFFIDDZ-UHFFFAOYSA-N 2-[2-[(2-bromo-5-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 FGRRSCLWFFIDDZ-UHFFFAOYSA-N 0.000 description 2
- PRRRRTXDJJLOLL-UHFFFAOYSA-N 2-[2-[(2-bromo-6-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC(Br)=C1CSC1=CC=CC=C1C1=NCCCN1 PRRRRTXDJJLOLL-UHFFFAOYSA-N 0.000 description 2
- HGTPFVATRKNXIH-UHFFFAOYSA-N 2-[2-[(2-bromophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound BrC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 HGTPFVATRKNXIH-UHFFFAOYSA-N 0.000 description 2
- KEDBEJDOVCGYMS-UHFFFAOYSA-N 2-[2-[(2-bromophenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound BrC1=CC=CC=C1SCC1=CC=CC=C1C1=NCCCN1 KEDBEJDOVCGYMS-UHFFFAOYSA-N 0.000 description 2
- IKNWNXHMEIPMHN-UHFFFAOYSA-N 2-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]phenyl]-3a,4,5,6,7,7a-hexahydro-1h-benzimidazole Chemical compound FC1=CC=CC(Cl)=C1CSC1=CC=CC=C1C(N1)=NC2C1CCCC2 IKNWNXHMEIPMHN-UHFFFAOYSA-N 0.000 description 2
- HNKHRELQAZCOCP-UHFFFAOYSA-N 2-[2-[(2-chloro-6-fluorophenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound FC1=CC=CC(Cl)=C1CSC1=CC=CC=C1C1=NCCN1 HNKHRELQAZCOCP-UHFFFAOYSA-N 0.000 description 2
- XUNKOLSVSAKVHQ-UHFFFAOYSA-N 2-[2-[(2-chlorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound ClC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 XUNKOLSVSAKVHQ-UHFFFAOYSA-N 0.000 description 2
- SMTXSQTYIZFVIR-UHFFFAOYSA-N 2-[2-[(2-cyclopentyloxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1CCCC1OC=1C=CC2=CC=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 SMTXSQTYIZFVIR-UHFFFAOYSA-N 0.000 description 2
- RLQOQTQCFAZGSR-UHFFFAOYSA-N 2-[2-[(2-ethoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CCOC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 RLQOQTQCFAZGSR-UHFFFAOYSA-N 0.000 description 2
- UEYAWOPDBOWKEK-UHFFFAOYSA-N 2-[2-[(2-fluorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 UEYAWOPDBOWKEK-UHFFFAOYSA-N 0.000 description 2
- AMSWPHUXJQRFBP-UHFFFAOYSA-N 2-[2-[(2-iodophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound IC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 AMSWPHUXJQRFBP-UHFFFAOYSA-N 0.000 description 2
- IZUJSZAYULSQCW-UHFFFAOYSA-N 2-[2-[(2-iodophenyl)methylsulfanyl]phenyl]-3a,4,5,6,7,7a-hexahydro-1h-benzimidazole Chemical compound IC1=CC=CC=C1CSC1=CC=CC=C1C(N1)=NC2C1CCCC2 IZUJSZAYULSQCW-UHFFFAOYSA-N 0.000 description 2
- JQMKHYYNAWZZBX-UHFFFAOYSA-N 2-[2-[(2-iodophenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound IC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCN1 JQMKHYYNAWZZBX-UHFFFAOYSA-N 0.000 description 2
- KKWGREIGMAWSGA-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-methylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C)C=C1CSC1=CC=CC=C1C1=NCCCN1 KKWGREIGMAWSGA-UHFFFAOYSA-N 0.000 description 2
- KTWWZGRWSAZNFV-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=CC=CC=C1C1=NCCCN1 KTWWZGRWSAZNFV-UHFFFAOYSA-N 0.000 description 2
- YSKONJARCLBXRG-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]phenyl]-3a,4,5,6,7,7a-hexahydro-1h-benzimidazole Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=CC=CC=C1C(N1)=NC2C1CCCC2 YSKONJARCLBXRG-UHFFFAOYSA-N 0.000 description 2
- XROZEKFUKUQTAT-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=CC=CC=C1C1=NCCN1 XROZEKFUKUQTAT-UHFFFAOYSA-N 0.000 description 2
- JLIDYMPVMLNLGY-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-nitrophenyl)methylsulfanyl]pyridin-3-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C([N+]([O-])=O)C=C1CSC1=NC=CC=C1C1=NCCCN1 JLIDYMPVMLNLGY-UHFFFAOYSA-N 0.000 description 2
- CGDASKIJYYWJSM-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-phenylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C=2C=CC=CC=2)C=C1CSC1=CC=CC=C1C1=NCCCN1 CGDASKIJYYWJSM-UHFFFAOYSA-N 0.000 description 2
- GMKOONYUECAQPJ-UHFFFAOYSA-N 2-[2-[(2-methoxy-5-thiophen-3-ylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C2=CSC=C2)C=C1CSC1=CC=CC=C1C1=NCCCN1 GMKOONYUECAQPJ-UHFFFAOYSA-N 0.000 description 2
- NUTDJMUUFLZXSZ-UHFFFAOYSA-N 2-[2-[(2-methoxynaphthalen-1-yl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1SCC1=CC=CC=C1C1=NCCCN1 NUTDJMUUFLZXSZ-UHFFFAOYSA-N 0.000 description 2
- VUQUNQSDLBZMCT-UHFFFAOYSA-N 2-[2-[(2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 VUQUNQSDLBZMCT-UHFFFAOYSA-N 0.000 description 2
- QRISVWPWDXQJMG-UHFFFAOYSA-N 2-[2-[(2-methoxyphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC=C1SCC1=CC=CC=C1C1=NCCCN1 QRISVWPWDXQJMG-UHFFFAOYSA-N 0.000 description 2
- ZAZUDFGPICAKDI-UHFFFAOYSA-N 2-[2-[(2-methylnaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 ZAZUDFGPICAKDI-UHFFFAOYSA-N 0.000 description 2
- MFWSRNUATFFCLO-UHFFFAOYSA-N 2-[2-[(2-methylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=CC=C1CSC1=CC=CC=C1C1=NCCCN1 MFWSRNUATFFCLO-UHFFFAOYSA-N 0.000 description 2
- LOPZEVFRRBDVPB-UHFFFAOYSA-N 2-[2-[(2-methylphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=CC=C1SCC1=CC=CC=C1C1=NCCCN1 LOPZEVFRRBDVPB-UHFFFAOYSA-N 0.000 description 2
- PHPOZVKYMNDMHX-UHFFFAOYSA-N 2-[2-[(2-phenylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1CSC1=CC=CC=C1C1=NCCCN1 PHPOZVKYMNDMHX-UHFFFAOYSA-N 0.000 description 2
- JURFLFGQSHDRQR-UHFFFAOYSA-N 2-[2-[(2-propan-2-yloxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC(C)OC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 JURFLFGQSHDRQR-UHFFFAOYSA-N 0.000 description 2
- MVFGKBOVQQMARR-UHFFFAOYSA-N 2-[2-[(2-propoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CCCOC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 MVFGKBOVQQMARR-UHFFFAOYSA-N 0.000 description 2
- YZQSLUVOBLBNMG-UHFFFAOYSA-N 2-[2-[(3,5-dimethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC(OC)=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 YZQSLUVOBLBNMG-UHFFFAOYSA-N 0.000 description 2
- COTASPQXFNVYQO-UHFFFAOYSA-N 2-[2-[(3-bromophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound BrC1=CC=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 COTASPQXFNVYQO-UHFFFAOYSA-N 0.000 description 2
- QCHPOPXUCRMGCY-UHFFFAOYSA-N 2-[2-[(3-chlorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound ClC1=CC=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 QCHPOPXUCRMGCY-UHFFFAOYSA-N 0.000 description 2
- GMDPNUDGOALJPG-UHFFFAOYSA-N 2-[2-[(3-iodophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound IC1=CC=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 GMDPNUDGOALJPG-UHFFFAOYSA-N 0.000 description 2
- YQXGBUCFRQYHMD-UHFFFAOYSA-N 2-[2-[(3-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 YQXGBUCFRQYHMD-UHFFFAOYSA-N 0.000 description 2
- IHIDTXABSJSEDM-UHFFFAOYSA-N 2-[2-[(3-nitrophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound [O-][N+](=O)C1=CC=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 IHIDTXABSJSEDM-UHFFFAOYSA-N 0.000 description 2
- OPPJDQNZBNINSH-UHFFFAOYSA-N 2-[2-[(3-phenylphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC(C=2C=CC=CC=2)=CC=1CSC1=CC=CC=C1C1=NCCCN1 OPPJDQNZBNINSH-UHFFFAOYSA-N 0.000 description 2
- KWBUUMUFWHBVGS-UHFFFAOYSA-N 2-[2-[(4-fluorophenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1=CC(F)=CC=C1CSC1=CC=CC=C1C1=NCCCN1 KWBUUMUFWHBVGS-UHFFFAOYSA-N 0.000 description 2
- AWWMCYRTRDYSLP-UHFFFAOYSA-N 2-[2-[(4-methylnaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C12=CC=CC=C2C(C)=CC=C1CSC1=CC=CC=C1C1=NCCCN1 AWWMCYRTRDYSLP-UHFFFAOYSA-N 0.000 description 2
- DRCKIXIPSQZHTF-UHFFFAOYSA-N 2-[2-[(4-phenylmethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=CC=1COC(C=C1)=CC=C1CSC1=CC=CC=C1C1=NCCCN1 DRCKIXIPSQZHTF-UHFFFAOYSA-N 0.000 description 2
- PUDQPIKMLRFZPN-UHFFFAOYSA-N 2-[2-[(5-bromo-2-cyclopentyloxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=C(C=2NCCCN=2)C=1SCC1=CC(Br)=CC=C1OC1CCCC1 PUDQPIKMLRFZPN-UHFFFAOYSA-N 0.000 description 2
- GPSOQGAPPIJCEG-UHFFFAOYSA-N 2-[2-[(5-bromo-2-ethoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CCOC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1 GPSOQGAPPIJCEG-UHFFFAOYSA-N 0.000 description 2
- PXBUAHNXIUFNNY-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methoxy]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1COC1=CC=CC=C1C1=NCCCN1 PXBUAHNXIUFNNY-UHFFFAOYSA-N 0.000 description 2
- CPJWCFKQCQUQLI-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methoxymethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1COCC1=CC=CC=C1C1=NCCCN1 CPJWCFKQCQUQLI-UHFFFAOYSA-N 0.000 description 2
- RGMPFJUALNCLIZ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3,4-difluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C(F)=CC=C1C1=NCCCN1 RGMPFJUALNCLIZ-UHFFFAOYSA-N 0.000 description 2
- BHRKIYVQKAPXBH-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3,5-difluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=C(F)C=C1C1=NCCCN1 BHRKIYVQKAPXBH-UHFFFAOYSA-N 0.000 description 2
- FOVOETZPEDCAOZ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3,5-difluorophenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=C(F)C=C1C1=NCC(C)(C)N1 FOVOETZPEDCAOZ-UHFFFAOYSA-N 0.000 description 2
- BVRSBCUMISUFPR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]-1,4,5,6-tetrahydropyrimidin-5-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1C1=NCC(O)CN1 BVRSBCUMISUFPR-UHFFFAOYSA-N 0.000 description 2
- ORJVHEZQRTWNPN-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1C1=NCCCN1 ORJVHEZQRTWNPN-UHFFFAOYSA-N 0.000 description 2
- DHGHRXKJJOANFR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]-5-methyl-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1C1=NC(C)CN1 DHGHRXKJJOANFR-UHFFFAOYSA-N 0.000 description 2
- WHXSLNWBYOEZBI-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluoro-4-(trifluoromethyl)phenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C(C(F)(F)F)=CC=C1C1=NC(C)(C)CN1 WHXSLNWBYOEZBI-UHFFFAOYSA-N 0.000 description 2
- QMZMGFFTHMWJGO-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluoro-4-(trifluoromethyl)phenyl]-5,5-dimethyl-4,6-dihydro-1h-pyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C(C(F)(F)F)=CC=C1C1=NCC(C)(C)CN1 QMZMGFFTHMWJGO-UHFFFAOYSA-N 0.000 description 2
- XDPJOQZPTYODRK-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCCCN1 XDPJOQZPTYODRK-UHFFFAOYSA-N 0.000 description 2
- RHYDIGSQSONJBK-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NC(C)(C)CN1 RHYDIGSQSONJBK-UHFFFAOYSA-N 0.000 description 2
- RTXJBQSGOVXPQR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5,5-dimethyl-4,6-dihydro-1h-pyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCC(C)(C)CN1 RTXJBQSGOVXPQR-UHFFFAOYSA-N 0.000 description 2
- OOYYKTSPPNPIOS-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5-methyl-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NC(C)CN1 OOYYKTSPPNPIOS-UHFFFAOYSA-N 0.000 description 2
- AKAKMYRPGCQWGD-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-5-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(F)C=C1C1=NCCCN1 AKAKMYRPGCQWGD-UHFFFAOYSA-N 0.000 description 2
- ZECWULPQHNOWRR-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-5-fluorophenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(F)C=C1C1=NCCN1 ZECWULPQHNOWRR-UHFFFAOYSA-N 0.000 description 2
- LRARSJZZXIOEEO-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-5-methylphenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(C)C=C1C1=NCCCN1 LRARSJZZXIOEEO-UHFFFAOYSA-N 0.000 description 2
- QMSDCVRXVFCLRL-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1 QMSDCVRXVFCLRL-UHFFFAOYSA-N 0.000 description 2
- JYSMBTPEJSZMPQ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCN1 JYSMBTPEJSZMPQ-UHFFFAOYSA-N 0.000 description 2
- NYPTVDKJISWLDP-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCC(C)(C)N1 NYPTVDKJISWLDP-UHFFFAOYSA-N 0.000 description 2
- WFGIAUVZRWXFIJ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5,5-dimethyl-4,6-dihydro-1h-pyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCC(C)(C)CN1 WFGIAUVZRWXFIJ-UHFFFAOYSA-N 0.000 description 2
- LNPRXFXPBRCTGB-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-5-methyl-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NC(C)CN1 LNPRXFXPBRCTGB-UHFFFAOYSA-N 0.000 description 2
- VFXNWSNBKZPTTD-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]guanidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1NC(N)=N VFXNWSNBKZPTTD-UHFFFAOYSA-N 0.000 description 2
- SMZVQYVSTZGACP-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)methylsulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSCC1=CC=CC=C1C1=NCCCN1 SMZVQYVSTZGACP-UHFFFAOYSA-N 0.000 description 2
- DIHXBZVYCWIMIW-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)sulfanylmethyl]-3-chlorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1SCC1=C(Cl)C=CC=C1C1=NCCCN1 DIHXBZVYCWIMIW-UHFFFAOYSA-N 0.000 description 2
- CXKQSXANCQVLRO-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)sulfanylmethyl]-3-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1SCC1=C(F)C=CC=C1C1=NCCCN1 CXKQSXANCQVLRO-UHFFFAOYSA-N 0.000 description 2
- IGCCPAKERWHUNZ-UHFFFAOYSA-N 2-[2-[(5-bromo-2-methoxyphenyl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1SCC1=CC=CC=C1C1=NCCCN1 IGCCPAKERWHUNZ-UHFFFAOYSA-N 0.000 description 2
- VJCWFTJNIJPWCW-UHFFFAOYSA-N 2-[2-[(5-bromo-2-propan-2-yloxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC(C)OC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1 VJCWFTJNIJPWCW-UHFFFAOYSA-N 0.000 description 2
- MUSSZQAYEUONGF-UHFFFAOYSA-N 2-[2-[(5-bromo-2-propoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CCCOC1=CC=C(Br)C=C1CSC1=CC=CC=C1C1=NCCCN1 MUSSZQAYEUONGF-UHFFFAOYSA-N 0.000 description 2
- YOHMIPZLDKWENG-UHFFFAOYSA-N 2-[2-[(5-chloro-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Cl)C=C1CSC1=CC=CC=C1C1=NCCCN1 YOHMIPZLDKWENG-UHFFFAOYSA-N 0.000 description 2
- NHYCLGJOZNTBRB-UHFFFAOYSA-N 2-[2-[(5-ethynyl-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C#C)C=C1CSC1=CC=CC=C1C1=NCCCN1 NHYCLGJOZNTBRB-UHFFFAOYSA-N 0.000 description 2
- XAJUEBVKLILWRA-UHFFFAOYSA-N 2-[2-[(5-fluoro-2-methoxyphenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(F)C=C1CSC1=CC=CC=C1C1=NCCN1 XAJUEBVKLILWRA-UHFFFAOYSA-N 0.000 description 2
- HJWLUEOYGAIIGV-UHFFFAOYSA-N 2-[2-[(5-iodo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(I)C=C1CSC1=CC=CC=C1C1=NCCCN1 HJWLUEOYGAIIGV-UHFFFAOYSA-N 0.000 description 2
- FYSBRELZWWDOLV-UHFFFAOYSA-N 2-[2-[(6-bromo-2-methoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=C(Br)C=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 FYSBRELZWWDOLV-UHFFFAOYSA-N 0.000 description 2
- TYHWUSYRUAHMBB-UHFFFAOYSA-N 2-[2-[(6-fluoronaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC(F)=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 TYHWUSYRUAHMBB-UHFFFAOYSA-N 0.000 description 2
- XZTTZBZEQYPTEC-UHFFFAOYSA-N 2-[2-[(6-methoxy-2,3-dihydro-1,4-benzodioxin-5-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2OCCOC2=C1CSC1=CC=CC=C1C1=NCCCN1 XZTTZBZEQYPTEC-UHFFFAOYSA-N 0.000 description 2
- FFFXXFREPCGSFR-UHFFFAOYSA-N 2-[2-[1-(5-bromo-2-methoxyphenyl)propan-2-yl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CC(C)C1=CC=CC=C1C1=NCCCN1 FFFXXFREPCGSFR-UHFFFAOYSA-N 0.000 description 2
- UCANUPCLAHKJLU-UHFFFAOYSA-N 2-[2-[2-(2,3-dihydro-1,4-benzodioxin-5-yl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC=2OCCOC=2C=1CCC1=CC=CC=C1C1=NCCCN1 UCANUPCLAHKJLU-UHFFFAOYSA-N 0.000 description 2
- GYJLBLSVLQVQOR-UHFFFAOYSA-N 2-[2-[2-(2-methoxynaphthalen-1-yl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1CCC1=CC=CC=C1C1=NCCCN1 GYJLBLSVLQVQOR-UHFFFAOYSA-N 0.000 description 2
- DSRUBXVCPSJSAX-UHFFFAOYSA-N 2-[2-[2-(2-methylnaphthalen-1-yl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound CC1=CC=C2C=CC=CC2=C1CCC1=CC=CC=C1C1=NCCCN1 DSRUBXVCPSJSAX-UHFFFAOYSA-N 0.000 description 2
- LVWCZTLURLTYFL-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]-3-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=C(C=2NCCCN=2)C=CC=C1C(F)(F)F LVWCZTLURLTYFL-UHFFFAOYSA-N 0.000 description 2
- GPVZZAYIPVQEAG-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]-3-fluorophenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=C(F)C=CC=C1C1=NCCCN1 GPVZZAYIPVQEAG-UHFFFAOYSA-N 0.000 description 2
- QMKKPQXQBBNKQM-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]-3-methoxyphenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=C(OC)C=CC=C1C1=NCCCN1 QMKKPQXQBBNKQM-UHFFFAOYSA-N 0.000 description 2
- WMSIKZDVBSROMD-UHFFFAOYSA-N 2-[2-[2-(5-bromo-2-methoxyphenyl)ethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CCC1=CC=CC=C1C1=NCCCN1 WMSIKZDVBSROMD-UHFFFAOYSA-N 0.000 description 2
- CCISHMCRIWHRTE-UHFFFAOYSA-N 2-[2-[[2,4-bis(trifluoromethyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC=C1CSC1=CC=CC=C1C1=NCCCN1 CCISHMCRIWHRTE-UHFFFAOYSA-N 0.000 description 2
- NAPYCAWRLDPGFK-UHFFFAOYSA-N 2-[2-[[2-methoxy-5-(2-phenylethynyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C#CC=2C=CC=CC=2)C=C1CSC1=CC=CC=C1C1=NCCCN1 NAPYCAWRLDPGFK-UHFFFAOYSA-N 0.000 description 2
- BQGMRZMJHCNXDE-UHFFFAOYSA-N 2-[2-[[2-methoxy-5-(4-methoxyphenyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C1=CC(OC)=CC=C1C1=CC=C(OC)C(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 BQGMRZMJHCNXDE-UHFFFAOYSA-N 0.000 description 2
- OXYGFGRBQBBYLQ-UHFFFAOYSA-N 2-[2-[[2-methoxy-5-(trifluoromethyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C(F)(F)F)C=C1CSC1=CC=CC=C1C1=NCCCN1 OXYGFGRBQBBYLQ-UHFFFAOYSA-N 0.000 description 2
- RBUZILJRVMVRED-UHFFFAOYSA-N 2-[2-[[3,5-bis(trifluoromethyl)phenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(CSC=2C(=CC=CC=2)C=2NCCCN=2)=C1 RBUZILJRVMVRED-UHFFFAOYSA-N 0.000 description 2
- RVZPOOQPQZLVQC-UHFFFAOYSA-N 2-[2-[[5-(3-chloro-4-fluorophenyl)-2-methoxyphenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C=2C=C(Cl)C(F)=CC=2)C=C1CSC1=CC=CC=C1C1=NCCCN1 RVZPOOQPQZLVQC-UHFFFAOYSA-N 0.000 description 2
- DAFVDEPYMPUPLS-UHFFFAOYSA-N 2-[2-[[5-(3-fluoro-4-phenylphenyl)-2-methoxyphenyl]methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(C=2C=C(F)C(=CC=2)C=2C=CC=CC=2)C=C1CSC1=CC=CC=C1C1=NCCCN1 DAFVDEPYMPUPLS-UHFFFAOYSA-N 0.000 description 2
- FSGARAUGNFHJCY-UHFFFAOYSA-N 2-[3-(naphthalen-1-ylsulfanylmethyl)thiophen-2-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1C=CSC=1C1=NCCCN1 FSGARAUGNFHJCY-UHFFFAOYSA-N 0.000 description 2
- SNXCNGBBNPGLHD-UHFFFAOYSA-N 2-[3-[(2-methoxynaphthalen-1-yl)sulfanylmethyl]thiophen-2-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1SCC=1C=CSC=1C1=NCCCN1 SNXCNGBBNPGLHD-UHFFFAOYSA-N 0.000 description 2
- HUQNTTQVZYURMS-UHFFFAOYSA-N 2-[3-[(5-bromo-2-methoxyphenyl)methylsulfanyl]pyridin-2-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CN=C1C1=NCCCN1 HUQNTTQVZYURMS-UHFFFAOYSA-N 0.000 description 2
- BTHAZOBIDZLSFQ-UHFFFAOYSA-N 2-[3-bromo-2-(naphthalen-1-ylsulfanylmethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1C(Br)=CC=CC=1C1=NCCCN1 BTHAZOBIDZLSFQ-UHFFFAOYSA-N 0.000 description 2
- XFWBPYOQWBEJDY-UHFFFAOYSA-N 2-[3-chloro-2-(2-naphthalen-1-ylethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(Cl)=CC=CC=1C1=NCCCN1 XFWBPYOQWBEJDY-UHFFFAOYSA-N 0.000 description 2
- JBPHWGGCJDJGDL-UHFFFAOYSA-N 2-[3-chloro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1C(Cl)=CC=CC=1C1=NCCCN1 JBPHWGGCJDJGDL-UHFFFAOYSA-N 0.000 description 2
- WUPHVXHCTSWGPA-UHFFFAOYSA-N 2-[3-chloro-2-[(2-methoxynaphthalen-1-yl)sulfanylmethyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1SCC1=C(Cl)C=CC=C1C1=NCCCN1 WUPHVXHCTSWGPA-UHFFFAOYSA-N 0.000 description 2
- VQPNUOOVVQVJAQ-UHFFFAOYSA-N 2-[3-fluoro-2-(2-naphthalen-1-ylethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(F)=CC=CC=1C1=NCCCN1 VQPNUOOVVQVJAQ-UHFFFAOYSA-N 0.000 description 2
- ONZWKMMEAIYJPY-UHFFFAOYSA-N 2-[3-fluoro-2-(2-naphthalen-1-ylethyl)phenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound N1C(C)(C)CN=C1C1=CC=CC(F)=C1CCC1=CC=CC2=CC=CC=C12 ONZWKMMEAIYJPY-UHFFFAOYSA-N 0.000 description 2
- VSLAWUJINZENSD-UHFFFAOYSA-N 2-[3-fluoro-2-(naphthalen-1-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CSC=1C(F)=CC=CC=1C1=NCCCN1 VSLAWUJINZENSD-UHFFFAOYSA-N 0.000 description 2
- XROBCDNMROGODT-UHFFFAOYSA-N 2-[3-fluoro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC=1C(F)=CC=CC=1C1=NCCCN1 XROBCDNMROGODT-UHFFFAOYSA-N 0.000 description 2
- QGYCEPCCNPOGMR-UHFFFAOYSA-N 2-[3-fluoro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]-5,5-dimethyl-1,4-dihydroimidazole Chemical compound N1C(C)(C)CN=C1C1=CC=CC(F)=C1CSC1=CC=CC2=CC=CC=C12 QGYCEPCCNPOGMR-UHFFFAOYSA-N 0.000 description 2
- WWQPTDNNDBFOLF-UHFFFAOYSA-N 2-[3-methoxy-2-(2-naphthalen-1-ylethyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CCC=1C(OC)=CC=CC=1C1=NCCCN1 WWQPTDNNDBFOLF-UHFFFAOYSA-N 0.000 description 2
- REYLZFXVSGOFRG-UHFFFAOYSA-N 2-[4-(naphthalen-1-ylmethylsulfanyl)phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1CSC(C=C1)=CC=C1C1=NCCCN1 REYLZFXVSGOFRG-UHFFFAOYSA-N 0.000 description 2
- CTHANELVHOFIDB-UHFFFAOYSA-N 2-[4-(naphthalen-1-ylsulfanylmethyl)thiophen-3-yl]-1,4,5,6-tetrahydropyrimidine Chemical compound C=1C=CC2=CC=CC=C2C=1SCC1=CSC=C1C1=NCCCN1 CTHANELVHOFIDB-UHFFFAOYSA-N 0.000 description 2
- IAHONBQOZYLKBE-UHFFFAOYSA-N 2-[4-bromo-2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC(Br)=CC=C1C1=NCCCN1 IAHONBQOZYLKBE-UHFFFAOYSA-N 0.000 description 2
- QQZLNBLGDXQLHB-UHFFFAOYSA-N 2-[5-bromo-2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(Br)C=C1C1=NCCCN1 QQZLNBLGDXQLHB-UHFFFAOYSA-N 0.000 description 2
- QZTCPOQRAKEEBS-UHFFFAOYSA-N 2-[5-bromo-2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]-4,5-dihydro-1h-imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=C(Br)C=C1C1=NCCN1 QZTCPOQRAKEEBS-UHFFFAOYSA-N 0.000 description 2
- ZDCKTYHRUDDTRR-UHFFFAOYSA-N 2-amino-2-[2-(2-naphthalen-1-ylethyl)phenyl]acetonitrile Chemical compound N#CC(N)C1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 ZDCKTYHRUDDTRR-UHFFFAOYSA-N 0.000 description 2
- YUPITEIZSJWQJT-UHFFFAOYSA-N 2-piperidin-1-ylethyl n-[2-[(2-methylnaphthalen-1-yl)methylsulfanyl]phenyl]carbamate Chemical compound CC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1NC(=O)OCCN1CCCCC1 YUPITEIZSJWQJT-UHFFFAOYSA-N 0.000 description 2
- PTIKYXSPQXDKMO-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)-n-[[2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]propan-1-amine Chemical compound CC1CCCCN1CCCNCC1=CC=CC=C1CSC1=CC=CC2=CC=CC=C12 PTIKYXSPQXDKMO-UHFFFAOYSA-N 0.000 description 2
- SNXAPSQAOUWUBO-UHFFFAOYSA-N 3-(2-naphthalen-1-ylethyl)-2-(1,4,5,6-tetrahydropyrimidin-2-yl)aniline Chemical compound NC1=CC=CC(CCC=2C3=CC=CC=C3C=CC=2)=C1C1=NCCCN1 SNXAPSQAOUWUBO-UHFFFAOYSA-N 0.000 description 2
- QVEWNZMMZGKMOK-UHFFFAOYSA-N 3-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyridine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCC2N1CCCC2 QVEWNZMMZGKMOK-UHFFFAOYSA-N 0.000 description 2
- NPCMACUQHBFXEO-UHFFFAOYSA-N 3-[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-fluorophenyl]-5,6,7,7a-tetrahydro-1h-pyrrolo[1,2-c]imidazole Chemical compound COC1=CC=C(Br)C=C1CSC1=C(F)C=CC=C1C1=NCC2N1CCC2 NPCMACUQHBFXEO-UHFFFAOYSA-N 0.000 description 2
- QAAXFJDGBDRGRQ-UHFFFAOYSA-N 3-[4-(dimethylamino)phenyl]-1-[3-(dimethylamino)propyl]-1-(naphthalen-1-ylmethyl)thiourea Chemical compound C=1C=CC2=CC=CC=C2C=1CN(CCCN(C)C)C(=S)NC1=CC=C(N(C)C)C=C1 QAAXFJDGBDRGRQ-UHFFFAOYSA-N 0.000 description 2
- NFZJLBMRYVVSKF-UHFFFAOYSA-N 3-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methoxy]piperidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1COC1CNCCC1 NFZJLBMRYVVSKF-UHFFFAOYSA-N 0.000 description 2
- KGMGBTYHOQWYMB-UHFFFAOYSA-N 3-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methoxy]pyrrolidine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1COC1CNCC1 KGMGBTYHOQWYMB-UHFFFAOYSA-N 0.000 description 2
- VRMGVFAVTFUVOZ-UHFFFAOYSA-N 3-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methylamino]-3-methylbutan-1-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CNC(C)(C)CCO VRMGVFAVTFUVOZ-UHFFFAOYSA-N 0.000 description 2
- YHFJHNVCVXVVEH-UHFFFAOYSA-N 3-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methylamino]propan-1-ol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CNCCCO YHFJHNVCVXVVEH-UHFFFAOYSA-N 0.000 description 2
- HLMAGOZCRZZHQE-UHFFFAOYSA-N 3-imidazol-1-yl-n-(naphthalen-1-ylmethyl)-n-(naphthalen-2-ylmethyl)propan-1-amine Chemical compound C=1C=C2C=CC=CC2=CC=1CN(CC=1C2=CC=CC=C2C=CC=1)CCCN1C=CN=C1 HLMAGOZCRZZHQE-UHFFFAOYSA-N 0.000 description 2
- RQCGBMCXRYEWNS-UHFFFAOYSA-N 4-[[2-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]sulfanylmethyl]quinoline Chemical compound C=1C=NC2=CC=CC=C2C=1CSC1=CC=CC=C1C1=NCCCN1 RQCGBMCXRYEWNS-UHFFFAOYSA-N 0.000 description 2
- IVLLVRGXVQYAEQ-UHFFFAOYSA-N 4-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]morpholine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1CCOCC1 IVLLVRGXVQYAEQ-UHFFFAOYSA-N 0.000 description 2
- XWXDYXQSASHOQE-UHFFFAOYSA-N 4-methoxy-3-[[2-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]sulfanylmethyl]benzonitrile Chemical compound COC1=CC=C(C#N)C=C1CSC1=CC=CC=C1C1=NCCCN1 XWXDYXQSASHOQE-UHFFFAOYSA-N 0.000 description 2
- MEAIANTWONFBMR-UHFFFAOYSA-N 5,5-dimethyl-2-[2-(2-naphthalen-1-ylethyl)phenyl]-1,4-dihydroimidazole Chemical compound N1C(C)(C)CN=C1C1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 MEAIANTWONFBMR-UHFFFAOYSA-N 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 229940126661 MC4 antagonist Drugs 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- DBIZGVXQPFDTDA-UHFFFAOYSA-N [1-[[2-(2-naphthalen-1-ylethyl)phenyl]methyl]piperidin-2-yl]methanol Chemical compound OCC1CCCCN1CC1=CC=CC=C1CCC1=CC=CC2=CC=CC=C12 DBIZGVXQPFDTDA-UHFFFAOYSA-N 0.000 description 2
- HKCYUJLPMMMRCF-UHFFFAOYSA-N [1-[[2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperidin-2-yl]methanol Chemical compound OCC1CCCCN1CC1=CC=CC=C1CSC1=CC=CC2=CC=CC=C12 HKCYUJLPMMMRCF-UHFFFAOYSA-N 0.000 description 2
- RECRHGNOHLGIHT-UHFFFAOYSA-N [1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CN1C(CO)CCC1 RECRHGNOHLGIHT-UHFFFAOYSA-N 0.000 description 2
- SWVFZCLSKWSBEH-UHFFFAOYSA-N [1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]piperidin-2-yl]methanol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1C(CO)CCCC1 SWVFZCLSKWSBEH-UHFFFAOYSA-N 0.000 description 2
- IFWBHPFZSKBIIQ-UHFFFAOYSA-N [1-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN1C(CO)CCC1 IFWBHPFZSKBIIQ-UHFFFAOYSA-N 0.000 description 2
- XGRRFBZSVWCCNA-UHFFFAOYSA-N [1-[[3-chloro-2-(naphthalen-1-ylsulfanylmethyl)phenyl]methyl]piperidin-2-yl]methanol Chemical compound OCC1CCCCN1CC1=CC=CC(Cl)=C1CSC1=CC=CC2=CC=CC=C12 XGRRFBZSVWCCNA-UHFFFAOYSA-N 0.000 description 2
- JMVNFIOCAYFCIY-UHFFFAOYSA-N [2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]phenyl]methanamine Chemical compound COC1=CC=C(Br)C=C1CSC1=CC=CC=C1CN JMVNFIOCAYFCIY-UHFFFAOYSA-N 0.000 description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 2
- 125000005157 alkyl carboxy group Chemical group 0.000 description 2
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- RHZAFXCZRSNAJI-UHFFFAOYSA-N ethyl 4-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methylamino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1NCC1=CC=CC(Cl)=C1SCC1=CC(Br)=CC=C1OC RHZAFXCZRSNAJI-UHFFFAOYSA-N 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- QIJLUZAUEGPNIB-UHFFFAOYSA-N n'-[(5-bromo-2-methoxyphenyl)methyl]-n,n-dimethyl-n'-(naphthalen-1-ylmethyl)propane-1,3-diamine Chemical compound COC1=CC=C(Br)C=C1CN(CCCN(C)C)CC1=CC=CC2=CC=CC=C12 QIJLUZAUEGPNIB-UHFFFAOYSA-N 0.000 description 2
- PUFRITGIUCXJFV-UHFFFAOYSA-N n,n-dimethyl-n'-(2-naphthalen-1-ylethyl)-n'-(naphthalen-1-ylmethyl)ethane-1,2-diamine Chemical compound C1=CC=C2C(CN(CCC=3C4=CC=CC=C4C=CC=3)CCN(C)C)=CC=CC2=C1 PUFRITGIUCXJFV-UHFFFAOYSA-N 0.000 description 2
- AZJXYSILXBMBDR-UHFFFAOYSA-N n,n-dimethyl-n'-(naphthalen-1-ylmethyl)-n'-(naphthalen-2-ylmethyl)propane-1,3-diamine Chemical compound C1=CC=C2C(CN(CC=3C=C4C=CC=CC4=CC=3)CCCN(C)C)=CC=CC2=C1 AZJXYSILXBMBDR-UHFFFAOYSA-N 0.000 description 2
- WHPBDZMNGAVUPV-UHFFFAOYSA-N n-[(3-bromophenyl)methyl]-1-(1-ethylpyrrolidin-2-yl)-n-(naphthalen-1-ylmethyl)methanamine Chemical compound CCN1CCCC1CN(CC=1C2=CC=CC=C2C=CC=1)CC1=CC=CC(Br)=C1 WHPBDZMNGAVUPV-UHFFFAOYSA-N 0.000 description 2
- SRNCFCZLRQCEOG-UHFFFAOYSA-N n-[(3-bromophenyl)methyl]-3-imidazol-1-yl-n-(naphthalen-1-ylmethyl)propan-1-amine Chemical compound BrC1=CC=CC(CN(CCCN2C=NC=C2)CC=2C3=CC=CC=C3C=CC=2)=C1 SRNCFCZLRQCEOG-UHFFFAOYSA-N 0.000 description 2
- MFQXYDQREGBJFS-UHFFFAOYSA-N n-[(5-bromo-2-methoxyphenyl)methyl]-1-(1-ethylpyrrolidin-2-yl)-n-(naphthalen-1-ylmethyl)methanamine Chemical compound CCN1CCCC1CN(CC=1C2=CC=CC=C2C=CC=1)CC1=CC(Br)=CC=C1OC MFQXYDQREGBJFS-UHFFFAOYSA-N 0.000 description 2
- ZHTYTQLZBHEOHT-UHFFFAOYSA-N n-[(5-bromo-2-methoxyphenyl)methyl]-2-(1,4,5,6-tetrahydropyrimidin-2-yl)aniline Chemical compound COC1=CC=C(Br)C=C1CNC1=CC=CC=C1C1=NCCCN1 ZHTYTQLZBHEOHT-UHFFFAOYSA-N 0.000 description 2
- RTHMKHFTQFJYGA-UHFFFAOYSA-N n-[(5-bromo-2-methoxyphenyl)methyl]-n-methyl-2-(1,4,5,6-tetrahydropyrimidin-2-yl)aniline Chemical compound COC1=CC=C(Br)C=C1CN(C)C1=CC=CC=C1C1=NCCCN1 RTHMKHFTQFJYGA-UHFFFAOYSA-N 0.000 description 2
- IUUWYNSTWKOEJX-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-n-(naphthalen-1-ylmethyl)naphthalene-2-sulfonamide Chemical compound C1=CC=CC2=CC(S(=O)(=O)N(CC=3C4=CC=CC=C4C=CC=3)CCN(C)C)=CC=C21 IUUWYNSTWKOEJX-UHFFFAOYSA-N 0.000 description 2
- SLCAGYISQJNUGD-UHFFFAOYSA-N n-[[1-(2-naphthalen-1-ylethyl)pyrrolidin-2-yl]methyl]-1h-pyrrol-2-amine Chemical compound C=1C=CC2=CC=CC=C2C=1CCN1CCCC1CNC1=CC=CN1 SLCAGYISQJNUGD-UHFFFAOYSA-N 0.000 description 2
- URCDELNWRSKOAA-UHFFFAOYSA-N n-[[2-[(5-bromo-2-methoxyphenyl)methylsulfanyl]-3-chlorophenyl]methyl]-3-(2-methylpiperidin-1-yl)propan-1-amine Chemical compound COC1=CC=C(Br)C=C1CSC1=C(Cl)C=CC=C1CNCCCN1C(C)CCCC1 URCDELNWRSKOAA-UHFFFAOYSA-N 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- JDLIHUYYNCQAES-UHFFFAOYSA-N 2-[2-[(2-methoxynaphthalen-1-yl)methylsulfanyl]phenyl]-1,4,5,6-tetrahydropyrimidine Chemical compound COC1=CC=C2C=CC=CC2=C1CSC1=CC=CC=C1C1=NCCCN1 JDLIHUYYNCQAES-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000001887 cyclopentyloxy group Chemical group C1(CCCC1)O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14728899P | 1999-08-04 | 1999-08-04 | |
| US60/147,288 | 1999-08-04 | ||
| US22327700P | 2000-08-03 | 2000-08-03 | |
| US60/223,277 | 2000-08-03 | ||
| PCT/US2000/021327 WO2001010842A2 (en) | 1999-08-04 | 2000-08-04 | Melanocortin-4 receptor binding compounds and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003528810A JP2003528810A (ja) | 2003-09-30 |
| JP2003528810A5 true JP2003528810A5 (https=) | 2007-09-20 |
Family
ID=26844785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001515309A Pending JP2003528810A (ja) | 1999-08-04 | 2000-08-04 | メラノコルチン−４受容体結合化合物及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1204645A2 (https=) |
| JP (1) | JP2003528810A (https=) |
| AU (1) | AU6621600A (https=) |
| BR (1) | BR0012984A (https=) |
| CA (1) | CA2381008A1 (https=) |
| MX (1) | MXPA02001160A (https=) |
| WO (1) | WO2001010842A2 (https=) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| CA2377369A1 (en) | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Substituted piperidines as melanocortin-4 receptor agonists |
| US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| US7375125B2 (en) * | 1999-08-04 | 2008-05-20 | Ore Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| US6699873B1 (en) | 1999-08-04 | 2004-03-02 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| EP1273571A4 (en) | 2000-04-14 | 2003-05-02 | Kureha Chemical Ind Co Ltd | NITROGEN COMPOUNDS AND ANTIVIRAL MEDICATIONS CONTAINING THEM |
| DZ3415A1 (fr) | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
| EP1339677B1 (en) * | 2000-10-30 | 2006-01-04 | Warner-Lambert Company LLC | Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| CN1486302A (zh) * | 2000-12-07 | 2004-03-31 | CV���ƹ�˾ | 作为抗冠状动脉疾病或动脉硬化的abca-1加强化合物的取代1,3,5-三嗪和嘧啶 |
| WO2002062766A2 (en) * | 2001-02-07 | 2002-08-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| AU2002238106A1 (en) | 2001-02-13 | 2002-08-28 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
| ES2278016T3 (es) | 2001-04-09 | 2007-08-01 | Novartis Vaccines And Diagnostics, Inc. | Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r). |
| US7115607B2 (en) | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
| US6977264B2 (en) | 2001-07-25 | 2005-12-20 | Amgen Inc. | Substituted piperidines and methods of use |
| US7354923B2 (en) | 2001-08-10 | 2008-04-08 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
| US7456184B2 (en) | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
| AU2002352878B2 (en) * | 2001-11-27 | 2007-11-22 | Merck Sharp & Dohme Corp. | 2-Aminoquinoline compounds |
| CA2467337A1 (en) | 2001-12-21 | 2003-07-10 | H. Lundbeck A/S | Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| US20030195187A1 (en) * | 2002-02-04 | 2003-10-16 | Chiron Corporation | Guanidino compounds |
| AU2003216274A1 (en) * | 2002-02-11 | 2003-09-04 | Neurocrine Biosciences, Inc. | Pyrrole derivatives as ligands of melanocortin receptors |
| MXPA04008901A (es) | 2002-03-13 | 2004-11-26 | Euro Celtique Sa | Pirimidinas arilo sustituidas y el uso de las mismas. |
| PT1551834E (pt) | 2002-05-23 | 2010-09-30 | Novartis Vaccines & Diagnostic | Compostos de quinazolinona substituídos |
| WO2003104240A1 (ja) * | 2002-06-11 | 2003-12-18 | 三共株式会社 | 環状チオエーテル類の製造法及びその合成中間体 |
| US7396930B2 (en) | 2002-06-11 | 2008-07-08 | Sankyo Company, Limited | Process for producing cyclic thioether and synthetic intermediate thereof |
| JP2004067673A (ja) * | 2002-06-11 | 2004-03-04 | Sankyo Co Ltd | 環状チオエーテル類の製造法及びその合成中間体 |
| GB2389581A (en) * | 2002-06-12 | 2003-12-17 | Viaxxel Biotech Gmbh | Hydrogenated pyrimidines and their use as inhibitors of deoxyhypusine-synthase or hypusination of eIF-5A |
| WO2004005324A2 (en) | 2002-07-09 | 2004-01-15 | Palatin Technologies, Inc. | Peptide composition for treatment of sexual dysfunction |
| AU2003261974A1 (en) | 2002-09-11 | 2004-04-30 | Kureha Chemical Industry Company, Limited | Amine compounds and use thereof |
| WO2004042351A2 (en) * | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| US7365070B2 (en) | 2002-12-04 | 2008-04-29 | Ore Pharmaceuticals Inc. | Modulators of melanocortin receptor |
| FR2852957B1 (fr) * | 2003-03-31 | 2005-06-10 | Sod Conseils Rech Applic | Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament |
| WO2004087156A1 (en) | 2003-04-04 | 2004-10-14 | H. Lundbeck A/S | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
| DE10316081A1 (de) * | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| CA2523015A1 (en) | 2003-05-23 | 2004-12-29 | Chiron Corporation | Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| MXPA06005736A (es) | 2003-11-19 | 2006-12-14 | Chiron Corp | Compuestos de quinazolinona con bioacumulacion reducida. |
| FR2862971B1 (fr) | 2003-11-28 | 2006-03-24 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
| PL1701940T3 (pl) | 2003-12-23 | 2008-11-28 | H Lundbeck As | Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI |
| JP3977411B2 (ja) | 2004-03-10 | 2007-09-19 | 株式会社クレハ | アミン系塩基性化合物とその用途 |
| AR052308A1 (es) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| US20070021433A1 (en) * | 2005-06-03 | 2007-01-25 | Jian-Qiang Fan | Pharmacological chaperones for treating obesity |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| TW200819426A (en) | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
| EP2103614A1 (en) * | 2008-03-18 | 2009-09-23 | Santhera Pharmaceuticals (Schweiz) AG | Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| EP2348857B1 (en) | 2008-10-22 | 2016-02-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| US8329914B2 (en) | 2008-10-31 | 2012-12-11 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| CA2759083A1 (en) | 2009-04-30 | 2010-11-04 | Novartis Ag | Imidazole derivatives and their use as modulators of cyclin dependent kinases |
| JP2013520502A (ja) | 2010-02-25 | 2013-06-06 | メルク・シャープ・エンド・ドーム・コーポレイション | 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体 |
| SG192941A1 (en) | 2011-02-25 | 2013-09-30 | Merck Sharp & Dohme | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| RU2015106909A (ru) | 2012-08-02 | 2016-09-27 | Мерк Шарп И Доум Корп. | Антидиабетические трициклические соединения |
| EP2951157A1 (en) | 2013-02-04 | 2015-12-09 | Merck Patent GmbH | Positive allosteric modulators of mglur3 |
| KR20150118158A (ko) | 2013-02-22 | 2015-10-21 | 머크 샤프 앤드 돔 코포레이션 | 항당뇨병 비시클릭 화합물 |
| WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| WO2016056606A1 (ja) * | 2014-10-07 | 2016-04-14 | 国立大学法人京都大学 | ベンゾイソチアゾロピリミジン誘導体またはその塩、およびウイルス感染阻害剤ならびに医薬品 |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| EP3558298B1 (en) | 2016-12-20 | 2026-03-11 | Merck Sharp & Dohme LLC | Antidiabetic spirochroman compounds |
| LT3483164T (lt) | 2017-03-20 | 2020-05-11 | Forma Therapeutics, Inc. | Pirolpirolo kompozicijos kaip piruvato kinazės (pkr) aktyvatoriai |
| CN108084109A (zh) * | 2017-12-21 | 2018-05-29 | 南京工业大学 | 一种2，5－二取代－1．3．4－噁二唑的合成方法 |
| EP3749697A4 (en) | 2018-02-05 | 2021-11-03 | Bio-Rad Laboratories, Inc. | CHROMATOGRAPHY RESIN WITH LIGAND MIXED MODE ANIONIC / HYDROPHOBIC EXCHANGE |
| CR20210175A (es) | 2018-09-18 | 2021-06-01 | Nikang Therapeutics Inc | Derivados de anillo tricíclico condensado como inhibidores de la fosfatasa de homología a src 2 (shp2) |
| EP3853206B1 (en) | 2018-09-19 | 2024-04-10 | Novo Nordisk Health Care AG | Treating sickle cell disease with a pyruvate kinase r activating compound |
| EP3852791B1 (en) | 2018-09-19 | 2024-07-03 | Novo Nordisk Health Care AG | Activating pyruvate kinase r |
| EP3861000A1 (en) | 2018-10-01 | 2021-08-11 | Genzyme Corporation | Thieno[3,2-b]pyridine derivatives as udp glycosyltransferase inhibitors and methods of use |
| HRP20251148T1 (hr) | 2019-09-19 | 2025-11-21 | Novo Nordisk Health Care Ag | Pripravci koji aktiviraju piruvat-kinazu r (pkr) |
| US11590209B2 (en) | 2020-01-21 | 2023-02-28 | Palatin Technologies, Inc. | Use of bremelanotide in patients with controlled hypertension |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI775313B (zh) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| KR20250133471A (ko) | 2020-02-18 | 2025-09-05 | 길리애드 사이언시즈, 인코포레이티드 | 항바이러스 화합물 |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| CA3216162A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| AU2022328698B2 (en) | 2021-08-18 | 2025-02-20 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3594380A (en) * | 1969-02-18 | 1971-07-20 | American Home Prod | Isoquinolin-1(2h)-ones |
| DE2219841A1 (de) * | 1972-04-22 | 1973-10-25 | Basf Ag | Verfahren zur herstellung von 2-(oalkylthiophenyl)-1,3-diazacycloalkenhydrohalogeniden |
| US4122263A (en) * | 1973-04-11 | 1978-10-24 | Basf Aktiengesellschaft | Production of 2-(o-alkylthiophenyl)-1,3-diazocycloalkene hydrohalides |
| DE3046366A1 (de) * | 1980-12-09 | 1982-07-08 | Bayer Ag, 5090 Leverkusen | Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung |
| GB8619971D0 (en) * | 1986-08-15 | 1986-09-24 | Fujisawa Pharmaceutical Co | Imidazole compounds |
| JPS63253073A (ja) * | 1987-04-08 | 1988-10-20 | Taisho Pharmaceut Co Ltd | ２−フエニルベンズイミダゾ−ル誘導体 |
| ZA923283B (en) * | 1991-05-29 | 1993-01-27 | Akzo Nv | Phenoxyphenyl derivatives |
| US5731408A (en) * | 1995-04-10 | 1998-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Peptides having potent antagonist and agonist bioactivities at melanocortin receptors |
| JPH09176871A (ja) * | 1995-12-25 | 1997-07-08 | Tamura Kaken Kk | 水溶性プリフラックス、プリント回路基板及びプリント回路基板の金属の表面処理方法 |
| US5932779A (en) * | 1996-06-10 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
| GB2338235B (en) * | 1997-04-15 | 2001-11-14 | Csir | Appetite suppressing plant extracts |
| EP0924209B1 (en) * | 1997-12-19 | 2003-05-02 | Eli Lilly And Company | Hypoglycemic imidazoline compounds |
| WO1999064002A1 (en) * | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
-
2000
- 2000-08-04 BR BR0012984-4A patent/BR0012984A/pt not_active Application Discontinuation
- 2000-08-04 JP JP2001515309A patent/JP2003528810A/ja active Pending
- 2000-08-04 CA CA002381008A patent/CA2381008A1/en not_active Abandoned
- 2000-08-04 WO PCT/US2000/021327 patent/WO2001010842A2/en not_active Ceased
- 2000-08-04 AU AU66216/00A patent/AU6621600A/en not_active Abandoned
- 2000-08-04 MX MXPA02001160A patent/MXPA02001160A/es active IP Right Grant
- 2000-08-04 EP EP00953837A patent/EP1204645A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003528810A5 (https=) | ||
| JP2009523812A5 (https=) | ||
| RU2406725C2 (ru) | Соединения и композиции как ингибиторы протеинкиназы | |
| RU2372347C2 (ru) | Соединения тетразола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
| JP2007523182A5 (https=) | ||
| RU2015106787A (ru) | Замещенные пирролы, активные в качестве ингибиторов киназ | |
| RU2430923C2 (ru) | Тиазолилдигидрохиназолины | |
| JP2022531801A5 (https=) | ||
| US9873683B2 (en) | P2X4 receptor antagonist | |
| RU2437882C2 (ru) | Производные имидазолидинона | |
| CA2534228A1 (en) | Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators | |
| RU2007146798A (ru) | ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА | |
| JP2006522812A5 (https=) | ||
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| RU2003101970A (ru) | Конденсированные производные азепина и их использование в качестве антидиуретических агентов | |
| RU2011100781A (ru) | 2-пиридил-замещенные имидазолы в качестве ингибиторов alk5 и/или alk4 | |
| CA2584567A1 (en) | Pyrazolo (1,5-alpha) pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists | |
| DE69110320D1 (de) | Stickstoff enthaltende heterozyklische Verbindungen, ihre Herstellung und Verwendung. | |
| RU2011111592A (ru) | Замещенные аминоинданы и их аналоги и их применение в фармацевтике | |
| JP2007500706A5 (https=) | ||
| JP2018518522A5 (https=) | ||
| RU2404163C2 (ru) | Производные 2,3,4,9-тетрагидро-1h-карбазола в качестве антагонистов рецептора crth2 | |
| RU2005120770A (ru) | Производные индазола, как антагонисты крф | |
| RU2012141607A (ru) | Производные аминоинданов, их получение и применение в терапии | |
| RU2008147543A (ru) | Агонисты мускариновых рецепторов, эффективные при лечении боли, болезни альцгеймера и шизофрении |